Caricamento...
Therapeutic Potential of Fluoxetine in Neurological Disorders
The selective serotonin reuptake inhibitor (SSRI) fluoxetine, which is registered for a variety of psychiatric disorders, has been found to stimulate the cAMP‐responsive element binding protein (CREB), increase the production of brain‐derived neurotrophic factor (BNDF) and the neurotrophic peptide S...
Salvato in:
| Pubblicato in: | CNS Neurosci Ther |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Blackwell Publishing Inc
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494017/ https://ncbi.nlm.nih.gov/pubmed/18482027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2008.00040.x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|